This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Maruho Co., Ltd., Mitsubishi Tanabe Pharma Corporation. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2017
Title: Hidetoshi Emi: Innovator in Ointment Formulation
Introduction
Hidetoshi Emi is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of pharmaceutical formulations, particularly in the development of ointments with enhanced stability and uniformity. His innovative work has led to the creation of a patented ointment that addresses critical issues in drug formulation.
Latest Patents
Hidetoshi Emi holds a patent for an ointment with excellent formulation stability. This ointment comprises 1 to 5% by weight of a specific compound, 3 to 7% by weight of a separation inhibitor, 15 to 50% by weight of a hydrocarbon gel, a pH controller, and 0.05 to 0.4% by weight of an antioxidant. The formulation is designed to ensure excellent drug stability and uniform dispersibility. The preferred components include polyoxyethylene (196) polyoxypropylene (67) glycol as the separation inhibitor, diisopropanolamine as the pH controller, and dibutylhydroxytoluene as the antioxidant.
Career Highlights
Throughout his career, Hidetoshi Emi has worked with prominent companies in the pharmaceutical industry. He has been associated with Maruho Co., Ltd. and Mitsubishi Tanabe Pharma Corporation, where he has contributed to various innovative projects and advancements in drug formulation.
Collaborations
Hidetoshi Emi has collaborated with Tomoki Sakaguchi, enhancing the research and development efforts in the field of pharmaceutical formulations.
Conclusion
Hidetoshi Emi's contributions to ointment formulation demonstrate his commitment to innovation in the pharmaceutical industry. His patented work reflects a significant advancement in drug stability and uniformity, showcasing the importance of research and development in creating effective pharmaceutical products.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile